4//SEC Filing
Trojer Patrick 4
Accession 0001562180-20-003454
CIK 0001434418other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 4:39 PM ET
Size
12.8 KB
Accession
0001562180-20-003454
Insider Transaction Report
Form 4
Trojer Patrick
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2020-05-06$7.60/sh+7,164$54,446→ 7,164 total - Exercise/Conversion
Common Stock
2020-05-06$5.62/sh+2,836$15,938→ 10,000 total - Sale
Common Stock
2020-05-06$45.16/sh−10,000$451,553→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-05-06−2,836→ 0 totalExercise: $5.62Exp: 2025-11-08→ Common Stock (2,836 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-05-06−7,164→ 33,330 totalExercise: $7.60Exp: 2028-03-05→ Common Stock (7,164 underlying)
Footnotes (4)
- [F1]These trades were made pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $45.00 to $45.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This option was granted on March 6, 2018, and the shares underlying the options vest in equal quarterly installments through March 6, 2022.
- [F4]This option was granted on November 9, 2015, and is fully vested.
Documents
Issuer
CONSTELLATION PHARMACEUTICALS INC
CIK 0001434418
Entity typeother
Related Parties
1- filerCIK 0001760185
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 4:39 PM ET
- Size
- 12.8 KB